US Patent 7858740 Exendin agonist compounds

Patent 7858740 was granted and assigned to Amylin Pharmaceuticals on December, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Amylin Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7858740

Date of Patent

December 28, 2010

Patent Application Number

11511738

Date Filed

August 28, 2006

Patent Citations Received

‌

US Patent 11884713 Acylated glucagon analogues

Patent Primary Examiner

‌

Michael Borin

Patent abstract

Novel exendin agonist compounds are provided. These compounds are useful in treating Type I and II diabetes and conditions which would be benefited by lower plasma glucose and delaying and/or slowing gastric emptying.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7858740 Exendin agonist compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API